CLINICAL_TRIALS research · 2016-11-15

Clinical Trial Update: GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals [Phase 1]

Phase 1 clinical trial investigating anti-reflux therapy for gastroesophageal reflux disease in able-bodied versus spinal cord injury individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Gastro Esophageal Reflux Disorder | Phase 1 | Status: UNKNOWN